Skip to search.
 TSX Up1.03% TSX Ventures 0.00%

Bristol-Myers Squibb Company (BMY)

-NYSE

44.06 May 21, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Total Revenue 17,621,000   21,244,000   19,484,000  
Cost of Revenue4,610,000  5,598,000  5,277,000  
Gross Profit 13,011,000   15,646,000   14,207,000  
Operating Expenses
Research Development3,904,000  3,839,000  3,566,000  
Selling General and Administrative5,017,000  5,160,000  4,663,000  
Non Recurring1,830,000   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 2,260,000   6,647,000   5,978,000  
Income from Continuing Operations
Total Other Income/Expenses Net80,000  334,000  93,000  
Earnings Before Interest And Taxes2,340,000  6,981,000  6,071,000  
Interest Expense -   -   -  
Income Before Tax2,340,000  6,981,000  6,071,000  
Income Tax Expense(161,000)1,721,000  1,558,000  
Minority Interest(541,000)(1,551,000)(1,411,000)
Net Income From Continuing Ops1,960,000  3,709,000  3,102,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 1,960,000   3,709,000   3,102,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 1,960,000   3,709,000   3,102,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.